Russian pharmacies are selling the drugs to counter a migraine at faster rates. About 490.9 thousand migraine medicine packs worth 121.9 million rubles were sold in May 2018. An increase of 3.1% and 1.3% is seen in real and value terms respectively as compared to May 2017. In just one month, a 0.5% increase was noticed in one package weighted average cost of 248.3 rubles.
According to the Russian information agency and publishers Remedium, the ARIA (All-Russian Union of Insurers) along with MHIF (Federal Compulsory Medical Insurance Fund) agreed to strengthen the health care system of Russia. The primary agenda of the collaboration will be the implementation of obligatory health insurance to improve the expertise of healthcare set-up.
Recently, the changes of the resolution #633 by the Russian Government coordinated Russian medical device registration requirements with Eurasian regulations. It also focused to clarify the In vitro diagnostic (IVD) and MD approval methodology.
As per the Pharmaceuticals Export Promotion Council of India, Russia was amongst the fourth countries (remaining were China, South Africa and Italy) to which exports progressed above 20% in 2017-18. These four countries contributed about 9% to the country’s pharma exports.
The US Pharmacopeial Convention (USP) and Russia's medical products regulator forged a three-year memorandum of understanding (MOU) earlier this week that will focus on harmonizing major pharmacopeial requirements and promoting the use of modern laboratory standards, among other things.
- 1 of 2